Mark Krueger

Chief Strategic Officer

Back to Speakers

Mark Krueger founded MK&A (Mark Krueger & Associates, Inc.) in 1996 to help pharmaceutical, biotech, device and diagnostic companies partner with patient, consumer and professional groups to speed drug development and approval, promote appropriate use, and ensure equitable access and reimbursement. He brings 25 years of public health and advocacy experience to the firm and has earned respect for his strategic approach to building equitable and responsible partnerships with patients, advocates, doctors and other health care professionals, and policy makers.
Under Krueger’s direction, MK&A has created a unique niche in global health care through its singular focus on patient engagement and patient advocacy. The firm has demonstrated repeatedly that integration of patient, consumer and professional groups’ viewpoints can create better health care for all. Notable among MK&A’s achievements are the return of thalidomide to legitimate use; registration and approval of 25 orphan drugs; planning and implementation of the largest pre-approval drug access program; resolution of conflicts with industry critics; building internal ally relations capacity from scratch in three global research and development-based pharmaceutical companies; and creation of guidelines and systems that promote equitable and compliant partnerships between industry and allies in North America, Europe, and other regions.
Prior to forming the firm, Krueger was vice president and director of coalition building for GTFH, then the largest public relations, marketing and government relations firm solely dedicated to health and medicine. Previously, he spent six years in a variety of senior management positions at the American Foundation for AIDS Research (amfAR), including special assistant to founding co-chair Mathilde Krim, Ph.D.
Krueger is recognized for his comprehensive knowledge of HIV/AIDS, other infectious diseases, oncology, women’s health, and orphan disorders. He is known for his mediation and moderation skills as well as his understanding of the changing external environment for ally relations and appropriate responses to legislative, regulatory, ally group, and public expectations.
Krueger holds a B.A. from the College of Columbia University and an M.P.H. from Columbia’s Joseph A. Mailman Graduate School of Public Health.